215 related articles for article (PubMed ID: 36142915)
1. Efficacy and Safety of Domperidone in Combination with Proton Pump Inhibitors in Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Zamani NF; Sjahid AS; Tuan Kamauzaman TH; Lee YY; Islam MA
J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36142915
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Review and Meta-analysis of Randomized Control Trials: Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease.
Jung DH; Huh CW; Lee SK; Park JC; Shin SK; Lee YC
J Neurogastroenterol Motil; 2021 Apr; 27(2):165-175. PubMed ID: 33795539
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial.
Foocharoen C; Chunlertrith K; Mairiang P; Mahakkanukrauh A; Suwannaroj S; Namvijit S; Wantha O; Nanagara R
Rheumatology (Oxford); 2017 Feb; 56(2):214-222. PubMed ID: 27179107
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Additive Effect of Domperidone on Patients with Refractory Gastroesophageal Reflux Disease; A Randomized Double Blind Clinical Trial.
Taghvaei T; Kazemi A; Hosseini V; Hamidian M; Tirgar Fakheri H; Hashemi SA; Maleki I
Middle East J Dig Dis; 2019 Jan; 11(1):24-31. PubMed ID: 31049179
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of potassium-competitive acid inhibitors in the treatment of gastroesophageal reflux: a systematic review and meta-analysis.
Zhou X; Duan H; Li Q; Wang Q; Sun X
Scand J Gastroenterol; 2024 Jul; 59(7):788-797. PubMed ID: 38741565
[TBL] [Abstract][Full Text] [Related]
6. The treatment efficacy of adding prokinetics to PPIs for gastroesophageal reflux disease: a meta-analysis.
Xi L; Zhu J; Zhang H; Muktiali M; Li Y; Wu A
Esophagus; 2021 Jan; 18(1):144-151. PubMed ID: 32519226
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients.
Foocharoen C; Kingkaew P; Teerawattananon Y; Mahakkanukrauh A; Suwannaroj S; Manasirisuk W; Chaiyarit J; Sangchan A
Int J Rheum Dis; 2023 Oct; 26(10):2037-2046. PubMed ID: 37665078
[TBL] [Abstract][Full Text] [Related]
8. Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis.
Ren LH; Chen WX; Qian LJ; Li S; Gu M; Shi RH
World J Gastroenterol; 2014 Mar; 20(9):2412-9. PubMed ID: 24605040
[TBL] [Abstract][Full Text] [Related]
9. Magnetic sphincter augmentation in treating refractory gastroesophageal reflux disease: A systematic review and meta-analysis.
Zhuang QJ; Tan ND; Chen SF; Zhang MY; Xiao YL
J Dig Dis; 2021 Dec; 22(12):695-705. PubMed ID: 34693633
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial.
Bell R; Lipham J; Louie B; Williams V; Luketich J; Hill M; Richards W; Dunst C; Lister D; McDowell-Jacobs L; Reardon P; Woods K; Gould J; Buckley FP; Kothari S; Khaitan L; Smith CD; Park A; Smith C; Jacobsen G; Abbas G; Katz P
Gastrointest Endosc; 2019 Jan; 89(1):14-22.e1. PubMed ID: 30031018
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of alginate formulations in patients with gastroesophageal reflux disease: a systematic review and meta-analysis of randomized controlled trials.
Zhao CX; Wang JW; Gong M
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11845-11857. PubMed ID: 33275256
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
13. Combination of PPI with a prokinetic drug in gastroesophageal reflux disease.
Ndraha S
Acta Med Indones; 2011 Oct; 43(4):233-6. PubMed ID: 22156354
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
[TBL] [Abstract][Full Text] [Related]
15. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
16. WITHDRAWN: Medical treatments in the short term management of reflux oesophagitis.
Moayyedi P; Santana J; Khan M; Preston C; Donnellan C
Cochrane Database Syst Rev; 2011 Feb; (2):CD003244. PubMed ID: 21328259
[TBL] [Abstract][Full Text] [Related]
17. Medical treatments in the short term management of reflux oesophagitis.
Khan M; Santana J; Donnellan C; Preston C; Moayyedi P
Cochrane Database Syst Rev; 2007 Apr; (2):CD003244. PubMed ID: 17443524
[TBL] [Abstract][Full Text] [Related]
18. On-demand Versus Continuous Maintenance Treatment of Gastroesophageal Reflux Disease With Proton Pump Inhibitors: A Systematic Review and Meta-analysis.
Kang SJ; Jung HK; Tae CH; Kim SY; Lee KJ
J Neurogastroenterol Motil; 2022 Jan; 28(1):5-14. PubMed ID: 34980685
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.
van der Pol RJ; Smits MJ; van Wijk MP; Omari TI; Tabbers MM; Benninga MA
Pediatrics; 2011 May; 127(5):925-35. PubMed ID: 21464183
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
